'Invisible' Stem Cells Evade Natural Killer Cells Using Immune 'Off-Switch'

UC San Francisco scientists have discovered a new way to control the immune system’s “natural killer” (NK) cells, a finding with implications for novel cell therapies and tissue implants that can evade immune rejection. The findings could also be used to enhance the ability of cancer immunotherapies

Cancer Metastasis is Target of New Research Initiative

Six UC San Francisco researchers have won an Endeavor Award to build a new research collaborative at the University focused on decoding the “rulebook” of metastatic cancer as a pathway to new treatments. The Mark Foundation for Cancer Research established the awards to support research challenges

Year in Review: 2020

This year was difficult for all of us, personally and collectively. The COVID-19 pandemic transformed every aspect of our lives and called for us to adapt in unprecedented ways. It was gratifying – yet not surprising – to see how the UCSF community met the challenges of 2020. In cancer, our care

Collaborations and Peers: A Lifetime of Research at UCSF

Byron C. Hann, MD, PhD, Research Scientist and Manager of the Preclinical Therapeutics Core at the Helen Diller Family Comprehensive Cancer Center will be retiring at the end of the month. Since his arrival in 1984, Dr. Hann has collaborated with UCSF's best and brightest scientists and helped to

UCSF, UCLA Gain FDA Approval for Prostate Cancer Imaging Technique

The University of California’s two nationally ranked medical centers, UC San Francisco and UCLA, and their nuclear medicine teams have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and

Big Data Powers Design of 'Smart' Cell Therapies for Cancer

Breast Cancer Study Hits 30K Milestone in Demystifying Risk

A national study evaluating a personalized approach to breast cancer screening and risk assessment has launched a new effort to diversify its participants, as it hits a milestone of 30,000 women enrolled. The multiyear WISDOM study (Women Informed to Screen Depending on Measures of risk), led by UC